Tracking

Mounjaro Tracker Guide: Logging Doses, Side Effects, and Glucose

GLP-1 Companion · 6 min read

People do not search for a Mounjaro tracker because they need another diabetes article. They search because the data is scattered: dose in one place, CGM in another, weight in another, side effects in memory, refill questions in email.

My position: a Mounjaro tracker is only useful if it respects the diabetes use case. Weight matters, but glucose, HbA1c, hypoglycemia context, side effects, and dose escalation are the data your clinician actually needs.

The Six Things to Log Weekly on Mounjaro

• Injection date and time.
• Dose (2.5, 5, 7.5, 10, 12.5, 15 mg).
• Injection site — abdomen, thigh, or upper arm.
• Side effects (1–10 scale): nausea, fatigue, GI, reflux.
• Weight, same morning each week.
• Fasting glucose and any CGM data if applicable.

Mounjaro Dose Schedule

Mounjaro escalates roughly every 4 weeks. Log each escalation explicitly — tirzepatide side effects, like semaglutide, tend to cluster in the 1–2 weeks following a dose increase.

1. Weeks 1–4: 2.5 mg weekly (starting dose, not therapeutic).
2. Weeks 5–8: 5 mg weekly (lowest maintenance dose).
3. Weeks 9–12: 7.5 mg if needed.
4. Weeks 13–16: 10 mg.
5. Weeks 17–20: 12.5 mg.
6. Week 21+: up to 15 mg for maximum efficacy.

Mounjaro Missed-Dose Rule

If you miss a dose, take it as soon as possible if it has been less than 4 days. If more than 4 days have passed, skip the missed dose and resume the regular weekly schedule. Do not double up. Note: This rule is identical for Zepbound, since it is the same molecule.

Pen Format

Mounjaro is a single-dose pen — one pen per weekly injection. Recording the dose strength in your log is essential because pens look very similar across strengths and a mix-up at a higher dose can cause severe GI side effects.

Side Effects Worth Logging on Tirzepatide

• Nausea — common, generally less severe than semaglutide at equivalent weight-loss potency in trials.
• Diarrhea — slightly more frequent on tirzepatide than semaglutide.
• Constipation — also common.
• Reflux and burping — often reported, log frequency over time.
• Decreased appetite (notable feature — log how it feels weekly: 1 = no change, 10 = unable to eat).
• Injection-site reactions — log site and reaction together.

Glucose Tracking for Diabetic Mounjaro Users

For type 2 diabetics on Mounjaro, glycemic tracking is at least as important as weight tracking.

• Fasting glucose, weekly or per CGM.
• HbA1c every 3 months. Tirzepatide produces some of the largest HbA1c reductions of any non-insulin therapy (often 2+ percentage points).
• Hypoglycemia episodes — note time, severity, and whether co-administered with insulin or sulfonylureas.
• CGM time-in-range, if you wear one.

Weight Tracking on Mounjaro

Tirzepatide produces substantial weight loss as a side effect of diabetic dosing — SURPASS trial data showed ~7–11 kg loss at 5–15 mg over 40 weeks. Weight tracking on Mounjaro follows the same principles as any GLP-1: weekly weigh-in, monthly measurements, monthly photos, 4-week trend reading. If your indication is diabetes, do not over-focus on the scale — HbA1c and time-in-range are the more important outputs.

Building Your Mounjaro Doctor-Visit Summary

1. Current dose, last escalation date.
2. HbA1c trend (most important for diabetic indication).
3. Fasting glucose summary or CGM time-in-range.
4. Weight trend over 12 weeks.
5. Top 3 side effects with severity over time.
6. Hypoglycemic events log.
7. Open questions for the visit.

For a diabetic on Mounjaro, the most valuable single output of a tracker is the side-by-side trend of HbA1c, weight, and side-effect severity. Together they tell your clinician whether to hold, escalate, or de-escalate.

Key Takeaways

• Log injection, dose, site, side effects, weight, and glucose weekly.
• Mounjaro escalates every 4 weeks; record every escalation date.
• Missed-dose rule: take within 4 days, otherwise skip.
• For diabetics, HbA1c and time-in-range matter more than the scale.
• A quarterly trend summary is the highest-value deliverable for clinician visits.

The right setup is usually two tools, not one: your glucose system for diabetes data and a GLP-1 tracker like Nuvo for dose, site, side effects, weight trend, and visit summaries.